Wolverine Trading
MRNA icon

Wolverine Trading’s Moderna MRNA Stock Holding History

Wolverine Trading’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12.9M Buy
+511,200
New +$14.3M 0.01% 797
2025
Q1 		– Sell
-283,800
Closed -$11.2M – 5437
2024
Q4 		$11.2M Sell
283,800
-10,200
-3% -$488K 0.01% 722
2024
Q3 		$19.3M Buy
294,000
+36,200
+14% +$3.32M 0.02% 451
2024
Q2 		$30.6M Buy
257,800
+111,700
+76% +$14.1M 0.03% 300
2024
Q1 		$15.6M Sell
146,100
-154,300
-51% -$15.6M 0.02% 487
2023
Q4 		$29.9M Buy
300,400
+75,300
+33% +$6.33M 0.03% 334
2023
Q3 		$23.3M Buy
225,100
+25,900
+13% +$2.89M 0.02% 328
2023
Q2 		$24.3M Buy
199,200
+33,600
+20% +$4.48M 0.03% 311
2023
Q1 		$24.4M Sell
165,600
-89,700
-35% -$14.8M 0.04% 299
2022
Q4 		$45.9M Buy
255,300
+39,200
+18% +$6.41M 0.07% 205
2022
Q3 		$25.5M Sell
216,100
-45,600
-17% -$6.92M 0.04% 253
2022
Q2 		$37.4M Sell
261,700
-88,300
-25% -$12.6M 0.06% 169
2022
Q1 		$61.2M Sell
350,000
-154,900
-31% -$26.1M 0.08% 143
2021
Q4 		$127M Sell
504,900
-47,700
-9% -$13.9M 0.15% 84
2021
Q3 		$209M Buy
552,600
+210,400
+61% +$77.6M 0.24% 47
2021
Q2 		$80.2M Buy
342,200
+97,000
+40% +$17.3M 0.12% 111
2021
Q1 		$29.1M Sell
245,200
-41,600
-15% -$6.03M 0.04% 284
2020
Q4 		$31.9M Buy
286,800
+107,700
+60% +$10.9M 0.05% 260
2020
Q3 		$12.6M Buy
179,100
+88,900
+99% +$6.2M 0.03% 445
2020
Q2 		$5.6M Buy
90,200
+43,200
+92% +$2.37M 0.02% 744
2020
Q1 		$1.43M Buy
+47,000
New +$1.08M ﹤0.01% 1624

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Wolverine Trading's MRNA Position: Q1 2025 in Review

Wolverine Trading sold out of Moderna (MRNA) in Q1 2025, closing a stake of 30,252 shares — an estimated $1.19M sold.

Wolverine Trading first reported a position in MRNA in Q1 2020 and held it in 18 quarters. The position peaked at $33.6M in Q4 2021. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Wolverine Trading reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 30,252 Moderna shares in Q1 2025, an estimated $1.19M.
  • Wolverine Trading first reported a position in Moderna in Q1 2020 and held it in 18 quarters.
  • Wolverine Trading's Moderna position peaked at $33.6M in Q4 2021.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.